PURE Bioscience (OTCMKTS:PURE) Announces Quarterly Earnings Results

PURE Bioscience (OTCMKTS:PURE) issued its quarterly earnings data on Monday. The company reported ($0.01) earnings per share (EPS) for the quarter, Zacks reports.

PURE Bioscience Price Performance

OTCMKTS PURE opened at $0.07 on Tuesday. The company has a market cap of $7.70 million, a P/E ratio of -1.72 and a beta of 0.35. The stock has a 50-day moving average of $0.07 and a two-hundred day moving average of $0.08. PURE Bioscience has a 1-year low of $0.05 and a 1-year high of $0.16.

PURE Bioscience Company Profile

PURE Bioscience, Inc develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds.